David leads international investments with a focus on biotech in Europe and Israel, and tech-enabled service/product delivery in South Asia and Sub-Saharan Africa. Since helping to establish the Strategic Investment Fund in 2010, he has led investments across a range of sectors and geographies including in Affinivax, Anacor, bKash, Halodoc, Immunocore, LumiraDx, Stellapps, Uversity and Visterra.
Prior to joining the foundation, David worked on deal teams in private equity and investment banking, where he was responsible for executing leveraged buyout, equity, debt, restructuring, and merger & acquisition transactions across a variety of industries.
David holds a B.A. in economics with an emphasis in finance from St. Olaf College.Back to all team members